Dr. Gary Matyas will receive $1,000,000 per year for five years to support his research on a vaccine that could treat heroin addiction while at the same time prevent HIV infection in those receiving the vaccine.
MUWRP celebrated 10 years of progress in research and HIV prevention, treatment and care at a ceremony held at the College of Health Sciences quadrangle in Kampala.
In the 30 May issue of The Lancet Infectious Diseases, MHRP researchers and collaborators provide important insights on behavioral and time variables that may have influenced the efficacy seen in the RV144 HIV vaccine study.
Today, the U.S. military continues to pursue the goal of developing a globally effective HIV vaccine to assist in the eventual eradication of HIV/AIDS.
